A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia.
第一作者:
Sara M A,Mohamed
第一单位:
Children's Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Kensington, NSW, Australia; School of Women's and Children's Health, UNSW Sydney, Kensington, NSW, Australia.; University of New South Wales Centre for Childhood Cancer Research, UNSW Sydney, Kensington, NSW, Australia; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
作者:
主题词
动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);儿童(Child);胞吞作用(Endocytosis);HEK293细胞(HEK293 Cells);人类(Humans);免疫球蛋白碎片(Immunoglobulin Fragments);小鼠(Mice);费城染色体(Philadelphia Chromosome);磷酰化(Phosphorylation);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);受体, 细胞因子(Receptors, Cytokine);重组蛋白质类(Recombinant Proteins);STAT5转录因子(STAT5 Transcription Factor);信号传导(Signal Transduction);单链抗体(Single-Chain Antibodies)
DOI
10.1016/j.ijbiomac.2021.08.194
PMID
34481852
发布时间
2021-12-15
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文